Report of Analysis
Client / Product Manufacturer
Authorized Clinical & Research Formulation Partner • Frankfurt am Main, Germany
Sample received: 08/12/26
Analysis conducted: 08/13/26
Certificate ID: BK-COA-923004
Batch / Lot: LOT-2026-102
Product: Aventra™ (Tirzepatide 10 mg) ↗
Appearance: Sterile lyophilized cake in borosilicate vial
Qualitative and quantitative chemical analysis by RP-HPLC with UV detection
Results
Identity: Aventra™ (Tirzepatide 10 mg)
Quantity: 10.32mg
Purity: 99.782%
DAD1 A, Sig=220,4 Ref=off
CHROMATE HPLC 300 250 200 150 100 0 mAU 5 10 15 20 min 16.128 min MAIN PEAK Area: 99.782%
Aventra™ (Tirzepatide 10 mg)
Tested Batch Vial